Home/Filings/4/0001104659-21-133630
4//SEC Filing

Altarac David 4

Accession 0001104659-21-133630

CIK 0001724344other

Filed

Nov 2, 8:00 PM ET

Accepted

Nov 3, 4:04 PM ET

Size

5.0 KB

Accession

0001104659-21-133630

Insider Transaction Report

Form 4
Period: 2021-11-02
Altarac David
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2021-11-02$2.94/sh3,669$10,78742,572 total
Footnotes (1)
  • [F1]Represents shares withheld solely for purposes of the payment of taxes arising in connection with the vesting of restricted stock units on November 2, 2021. The number of shares withheld was determined based on the closing price on the last trading day prior to vesting, which was November 1, 2021.

Issuer

Entasis Therapeutics Holdings Inc.

CIK 0001724344

Entity typeother

Related Parties

1
  • filerCIK 0001792615

Filing Metadata

Form type
4
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:04 PM ET
Size
5.0 KB